交易 ABVC BioPharma, Inc. - ABVC CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | - | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|
ABVC BioPharma, Inc. Events
时间(协调世界时) (UTC) | 国家/地区 | 事件 |
---|---|---|
Monday, August 14, 2023 | ||
时间(协调世界时) (UTC) 10:59 | 国家/地区 US
| 事件 Q2 2023 ABVC Biopharma Inc Earnings Release Q2 2023 ABVC Biopharma Inc Earnings ReleaseForecast -Previous - |
Monday, November 13, 2023 | ||
时间(协调世界时) (UTC) 21:00 | 国家/地区 US
| 事件 Q3 2023 ABVC Biopharma Inc Earnings Release Q3 2023 ABVC Biopharma Inc Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 0.96978 | 0.3558 | 0.48305 | 0.70172 | 0.00696 |
收入 | 0.96978 | 0.3558 | 0.48305 | 0.70172 | 0.00696 |
收入成本,共计 | 0.28642 | 0.00509 | 0.01872 | 0.02014 | 0.18528 |
毛利 | 0.68336 | 0.35071 | 0.46433 | 0.68158 | -0.17832 |
总营业费用 | 16.1943 | 12.0618 | 9.95004 | 4.1605 | 5.40463 |
销售/一般/行政费用,总计 | 13.1043 | 11.0529 | 8.42045 | 3.09181 | 1.61752 |
研究与开发 | 2.69346 | 1.00381 | 0.54966 | 1.04855 | 0.98872 |
营业收入 | -15.2245 | -11.706 | -9.46699 | -3.45878 | -5.39767 |
利息收入(费用),非经营净值 | -0.37306 | -0.02754 | -1.54658 | -0.66835 | -1.03872 |
税前净收入 | -15.5146 | -11.2108 | -10.8139 | -4.01028 | -6.42963 |
税后净收入 | -16.3124 | -12.0358 | -10.5936 | -3.93324 | -6.06453 |
未计算非常项目前的净收益 | -16.4232 | -12.8388 | -9.79116 | -3.64178 | -5.57538 |
净收入 | -16.4232 | -12.8388 | -9.79116 | -3.64178 | -5.57538 |
普通股股东可获收益 (不含非经常性项目) | -16.4232 | -12.8388 | -9.79116 | -3.64178 | -5.57538 |
普通股股东可获收益 (含非經常性項目) | -16.4232 | -12.8388 | -9.79116 | -3.64178 | -5.57538 |
摊薄净收入 | -16.4232 | -12.8388 | -9.79116 | -3.64178 | -5.57538 |
摊薄后加权平均股 | 31.6647 | 25.0535 | 19.7156 | 17.4985 | 11.6071 |
扣除特别项目的每股摊薄盈利 | -0.51866 | -0.51246 | -0.49662 | -0.20812 | -0.48034 |
每股正常摊薄盈利 | -0.5164 | -0.51246 | -0.46493 | -0.20812 | -0.33401 |
非常规项目总计 | |||||
Dividends per Share - Common Stock Primary Issue | |||||
异常费用(收入) | 0.11013 | 0 | 0.96122 | 2.61311 | |
其他,净值 | 0.083 | 0.52268 | 0.19964 | 0.11685 | 0.00677 |
少数股东权益 | -0.11087 | -0.80296 | 0.80242 | 0.29146 | 0.48915 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
总收入 | 0.12827 | 0.58899 | 0.04227 | 0.31286 | 0.02566 |
收入 | 0.12827 | 0.58899 | 0.04227 | 0.31286 | 0.02566 |
收入成本,共计 | 0.06024 | 0.26541 | 0.01074 | 0.00837 | 0.0019 |
毛利 | 0.06803 | 0.32358 | 0.03153 | 0.30449 | 0.02376 |
总营业费用 | 2.03446 | 3.83211 | 3.75811 | 2.35972 | 6.24438 |
销售/一般/行政费用,总计 | 1.63924 | 1.96079 | 3.44189 | 1.81857 | 5.88308 |
研究与开发 | 0.33498 | 1.49579 | 0.30548 | 0.53278 | 0.3594 |
营业收入 | -1.90619 | -3.24312 | -3.71584 | -2.04686 | -6.21872 |
利息收入(费用),非经营净值 | -0.01621 | -0.35877 | -0.07855 | 0.03473 | 0.02953 |
其他,净值 | 0.02517 | 0.06386 | 0.02209 | -0.01766 | 0.01471 |
税前净收入 | -1.89723 | -3.53803 | -3.7723 | -2.02978 | -6.17448 |
税后净收入 | -1.89723 | -4.5009 | -3.77652 | -1.94733 | -6.08762 |
少数股东权益 | 0.07354 | -0.36304 | 0.07166 | 0.08834 | 0.09218 |
未计算非常项目前的净收益 | -1.8237 | -4.86394 | -3.70486 | -1.859 | -5.99544 |
净收入 | -1.8237 | -4.86394 | -3.70486 | -1.859 | -5.99544 |
普通股股东可获收益 (不含非经常性项目) | -1.8237 | -4.86394 | -3.70486 | -1.859 | -5.99544 |
普通股股东可获收益 (含非經常性項目) | -1.8237 | -4.86394 | -3.70486 | -1.859 | -5.99544 |
摊薄净收入 | -1.8237 | -4.86394 | -3.70486 | -1.859 | -5.99544 |
摊薄后加权平均股 | 33.0758 | 33.0784 | 32.5746 | 31.3073 | 29.6834 |
扣除特别项目的每股摊薄盈利 | -0.05514 | -0.14704 | -0.11373 | -0.05938 | -0.20198 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.05514 | -0.14488 | -0.11373 | -0.05938 | -0.20198 |
异常费用(收入) | 0.11013 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 2.98725 | 9.62512 | 6.17297 | 0.87824 | 0.56648 |
现金和短期投资 | 0.16106 | 5.9367 | 4.27321 | 0.1443 | 0.22669 |
Cash | |||||
应收账款总额,净额 | 1.36949 | 1.71271 | 0.9994 | 0.64053 | 0.09848 |
Total Assets | 9.85548 | 13.698 | 11.6067 | 6.92781 | 5.94012 |
Other Long Term Assets, Total | 3.14966 | 1.14238 | 1.95543 | 1.63958 | 1.37541 |
Total Current Liabilities | 5.81953 | 3.69231 | 4.84439 | 6.81419 | 10.9878 |
Accounts Payable | 0 | 0.02304 | 0.024 | 0 | |
Accrued Expenses | 3.2789 | 1.6479 | 2.43503 | 2.31182 | 1.24316 |
Notes Payable/Short Term Debt | 1.89375 | 1.64 | 1.8358 | 2.0187 | 1.4097 |
Other Current Liabilities, Total | 0.64688 | 0.40441 | 0.30052 | 0.43877 | 7.7451 |
Total Liabilities | 6.75689 | 4.85438 | 8.16837 | 7.07878 | 11.5981 |
Total Long Term Debt | 0 | 0 | 2.6244 | 0 | 0.26526 |
Total Equity | 3.09859 | 8.84365 | 3.43834 | -0.15096 | -5.658 |
Common Stock | 0.03286 | 0.02893 | 0.02442 | 0.01948 | 0.01189 |
Additional Paid-In Capital | 67.9075 | 58.1137 | 40.7518 | 28.1803 | 14.9837 |
Retained Earnings (Accumulated Deficit) | -54.9044 | -38.4812 | -25.6424 | -15.8512 | -12.2094 |
Total Liabilities & Shareholders’ Equity | 9.85548 | 13.698 | 11.6067 | 6.92781 | 5.94012 |
Total Common Shares Outstanding | 32.8573 | 28.9263 | 24.4205 | 19.4782 | 11.8848 |
现金等价物 | 0.08527 | 5.82855 | 4.27321 | 0.1443 | 0.22669 |
Accounts Receivable - Trade, Net | 0.85567 | 0.42609 | 0.30315 | 0.30684 | 0 |
Total Inventory | 0 | 0.02598 | 0 | 0 | 0.00132 |
Prepaid Expenses | 0.15024 | 1.21307 | 0.17219 | 0.07727 | 0.2239 |
Other Current Assets, Total | 1.30646 | 0.73667 | 0.72816 | 0.01615 | 0.01609 |
Property/Plant/Equipment, Total - Net | 1.73512 | 1.99778 | 2.28758 | 1.04538 | 0.51007 |
Property/Plant/Equipment, Total - Gross | 5.03958 | 5.31225 | 5.58627 | 4.28667 | 0.76247 |
Accumulated Depreciation, Total | -3.30446 | -3.31447 | -3.29869 | -3.24129 | -0.2524 |
Long Term Investments | 0.84207 | 0.93276 | 1.19073 | 3.36462 | 3.48817 |
Current Port. of LT Debt/Capital Leases | 0 | 0.25 | 2.0209 | 0.58984 | |
Long Term Debt | 0 | 2.6244 | 0 | 0.26526 | |
Minority Interest | 0.13755 | 0.02669 | -0.77627 | 0.02615 | 0.31761 |
Other Liabilities, Total | 0.79981 | 1.13538 | 1.47585 | 0.23844 | 0.02747 |
Treasury Stock - Common | -9.1 | -9.1 | -9.1 | -9.1 | -9.1 |
Other Equity, Total | -0.83731 | -1.71774 | -2.5955 | -3.39957 | 0.65585 |
短期投资 | 0.0758 | 0.10815 | |||
Goodwill, Net | 0 | ||||
Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
Note Receivable - Long Term | 1.14138 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 3.48006 | 2.98725 | 2.90308 | 9.78939 | 7.98793 |
现金和短期投资 | 1.21297 | 0.16106 | 1.40113 | 2.99337 | 2.81349 |
现金等价物 | 1.13496 | 0.08527 | 1.32354 | 2.91061 | 2.71794 |
应收账款总额,净额 | 1.26231 | 1.36949 | 0.54768 | 4.14502 | 3.14197 |
Accounts Receivable - Trade, Net | 0.74233 | 0.85567 | 0.04768 | 0.4317 | 0.4266 |
Total Inventory | 0 | 0.02049 | 0.02186 | 0.0227 | |
Prepaid Expenses | 0.34785 | 0.15024 | 0.28718 | 1.94052 | 1.29512 |
Other Current Assets, Total | 0.65692 | 1.30646 | 0.6466 | 0.68863 | 0.71465 |
Total Assets | 10.7349 | 9.85548 | 10.4806 | 13.7826 | 12.0668 |
Property/Plant/Equipment, Total - Net | 1.67034 | 1.73512 | 1.81068 | 1.89187 | 1.98134 |
Property/Plant/Equipment, Total - Gross | 4.98422 | 5.03958 | 5.09896 | 5.19408 | 5.29062 |
Accumulated Depreciation, Total | -3.31388 | -3.30446 | -3.28828 | -3.30221 | -3.30928 |
Long Term Investments | 0.84984 | 0.84207 | 0.81616 | 0.87057 | 0.90425 |
Other Long Term Assets, Total | 3.48877 | 3.14966 | 3.76069 | 1.23078 | 1.19323 |
Total Current Liabilities | 5.07494 | 5.81953 | 3.89431 | 3.64586 | 3.6637 |
Accounts Payable | 0.00209 | ||||
Payable/Accrued | |||||
Accrued Expenses | 3.1506 | 3.2789 | 1.56525 | 1.59718 | 1.59657 |
Notes Payable/Short Term Debt | 0.902 | 1.89375 | 1.86625 | 1.574 | 1.60975 |
Current Port. of LT Debt/Capital Leases | |||||
Other Current Liabilities, Total | 1.02233 | 0.64688 | 0.46281 | 0.4726 | 0.45738 |
Total Liabilities | 9.06445 | 6.75689 | 4.56189 | 4.44829 | 4.63988 |
Total Long Term Debt | 3.20659 | 0 | 0 | 0 | 0 |
Long Term Debt | 3.20659 | ||||
Minority Interest | 0.06402 | 0.13755 | -0.22548 | -0.15382 | -0.06549 |
Other Liabilities, Total | 0.71891 | 0.79981 | 0.89306 | 0.95625 | 1.04167 |
Total Equity | 1.67049 | 3.09859 | 5.91868 | 9.33432 | 7.42688 |
Common Stock | 0.03308 | 0.03286 | 0.03263 | 0.03231 | 0.03031 |
Additional Paid-In Capital | 68.048 | 67.9075 | 66.4937 | 66.2405 | 62.5785 |
Retained Earnings (Accumulated Deficit) | -56.7281 | -54.9044 | -50.0405 | -46.3356 | -44.4766 |
Treasury Stock - Common | -9.1 | -9.1 | -9.1 | -9.1 | -9.1 |
Other Equity, Total | -0.58246 | -0.83731 | -1.4671 | -1.50282 | -1.60534 |
Total Liabilities & Shareholders’ Equity | 10.7349 | 9.85548 | 10.4806 | 13.7826 | 12.0668 |
Total Common Shares Outstanding | 33.0807 | 32.8573 | 32.6323 | 32.3073 | 30.3073 |
短期投资 | 0.07801 | 0.0758 | 0.07758 | 0.08276 | 0.09555 |
Goodwill, Net | 0 | 0 | |||
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Note Receivable - Long Term | 1.24593 | 1.14138 | 1.18996 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -16.3124 | -12.0358 | -10.5936 | -3.93324 | -6.06453 |
经营活动产生的现金 | -7.39839 | -7.59772 | -4.56392 | -3.13453 | -0.90053 |
非现金物品 | 7.38982 | 5.2157 | 6.30216 | 0.22665 | 3.41079 |
Cash Taxes Paid | 0.0016 | 0 | 0 | 0.00205 | 0.00185 |
已付现金利息 | 0.28547 | 0.33387 | 0.20856 | 0.16713 | 0.21054 |
营运资金的变化 | 0.63557 | -1.61376 | -0.08643 | 0.59767 | 2.07655 |
融资活动产生的现金 | 4.01393 | 9.99555 | 9.56784 | 3.08749 | 0.89686 |
融资现金流项目 | 0 | -0.85043 | |||
股票的发行(报废),净额 | 3.66393 | 11.1194 | 7.61533 | 1.08411 | |
债务的发行(退还),净额 | 0.35 | -0.27347 | 1.95251 | 2.00338 | 0.89686 |
现金净变化 | -5.17349 | 1.56384 | 4.84093 | -0.08234 | -0.16406 |
经营活动产生的现金 | 0.0238 | 0.01199 | 0.03714 | 0.05509 | 0.04361 |
Deferred Taxes | 0.8648 | 0.8242 | -0.2232 | -0.08069 | -0.36695 |
投资活动产生的现金 | -1.72168 | -0.80597 | -0.22543 | -0.0353 | -0.15637 |
其他投资现金流量项目,总计 | -1.60199 | -0.78846 | -0.22543 | -0.0353 | -0.15637 |
外汇效应 | -0.06734 | -0.02802 | 0.06244 | 0 | -0.00402 |
资本支出 | -0.11969 | -0.0175 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -1.89723 | -16.3124 | -11.8115 | -8.03495 | -6.08762 |
Cash From Operating Activities | -1.49763 | -7.39839 | -6.93732 | -6.42362 | -2.99426 |
Cash From Operating Activities | 0.00649 | 0.0238 | 0.01736 | 0.0109 | 0.00541 |
Deferred Taxes | 0 | 0.8648 | -0.03125 | -0.17012 | -0.08687 |
Non-Cash Items | 0.36497 | 7.38982 | 5.696 | 4.93657 | 4.70151 |
Cash Taxes Paid | 0 | 0.0016 | 0.0016 | 0 | 0 |
Cash Interest Paid | 0.05666 | 0.28547 | 0.16174 | 0.02435 | 0.04384 |
Changes in Working Capital | 0.02814 | 0.63557 | -0.80797 | -3.16603 | -1.52669 |
Cash From Investing Activities | 0 | -1.72168 | -1.6384 | -0.11525 | -0.09322 |
Other Investing Cash Flow Items, Total | -1.60199 | -1.51879 | 0 | 0 | |
Cash From Financing Activities | 2.20659 | 4.01393 | 4.26743 | 3.66393 | 0 |
Issuance (Retirement) of Stock, Net | 3.66393 | 3.91743 | 3.66393 | 0 | |
Issuance (Retirement) of Debt, Net | 2.20659 | 0.35 | 0.35 | 0 | 0 |
Foreign Exchange Effects | -0.3088 | -0.06734 | -0.28678 | -0.09103 | -0.04515 |
Net Change in Cash | 0.40015 | -5.17349 | -4.59507 | -2.96597 | -3.13263 |
Capital Expenditures | 0 | -0.11969 | -0.1196 | -0.11525 | -0.09322 |
Financing Cash Flow Items | 0 | 0 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
YuanGene, Corp | Corporation | 25.081 | 8296968 | 0 | 2023-05-10 | LOW |
Jiang (Tsung-Shann) | Individual Investor | 11.1357 | 3683784 | 0 | 2023-05-10 | LOW |
Jiang (Eugene) | Individual Investor | 2.1228 | 702246 | 0 | 2023-05-10 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.1714 | 387513 | 12000 | 2023-03-31 | LOW |
Odaira (Yoshinobu) | Individual Investor | 0.4949 | 163702 | 0 | 2023-05-10 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.421 | 139282 | 0 | 2023-03-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.139 | 45973 | 45973 | 2023-03-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.1241 | 41055 | 1434 | 2023-03-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.0557 | 18421 | 0 | 2023-03-31 | LOW |
Doong (Howard) | Individual Investor | 0.0556 | 18404 | 0 | 2023-05-10 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.0421 | 13923 | 3897 | 2023-03-31 | MED |
Tower Research Capital LLC | Hedge Fund | 0.0401 | 13254 | -994 | 2023-03-31 | HIGH |
Jiang (Tsang Ming) | Individual Investor | 0.0183 | 6067 | 0 | 2023-05-10 | LOW |
Chou (Yen-Hsin) | Individual Investor | 0.0172 | 5679 | 0 | 2023-05-10 | LOW |
Chung (Yu- Min) | Individual Investor | 0.0168 | 5556 | 0 | 2023-05-10 | LOW |
Jiang (Chang-Jen) | Individual Investor | 0.0168 | 5545 | 0 | 2023-05-10 | LOW |
Sakamoto (Norimi) | Individual Investor | 0.0141 | 4667 | 0 | 2023-05-10 | LOW |
Hsu (Che Wei) | Individual Investor | 0.0101 | 3346 | 0 | 2023-05-10 | LOW |
Chow (Leeds) | Individual Investor | 0.0082 | 2728 | 0 | 2023-05-10 | LOW |
Lord, Abbett & Co. LLC | Investment Advisor | 0.0048 | 1592 | 0 | 2023-03-31 | MED |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ABVC BioPharma, Inc. Company profile
关于 ABVC BioPharma Inc.
ABVC生物制药公司(ABVC),前身是美国BriVision(控股)公司,是一家专注于药物和医疗设备开发的生物技术公司。 公司专注于通过跟踪研究机构的医学发现或医疗设备技术来开发其管道。 ABVC有大约六种药物和三种医疗设备正在开发中。 公司的管线包括ABV-1501、ABV-1504、ABV-1505、ABV-1702、ABV-1703、ABV-1601、ABV-1701、ABV-2001和ABV-2002。 ABV-1501是一种治疗三阴性乳腺癌(TNBC)的综合疗法。 ABV-1504是一种针对去甲肾上腺素的植物性再摄取抑制剂。 ABVC正在开发ABV-1505,用于治疗注意力缺陷多动障碍(ADHD)。 ABV-1702是治疗骨髓增生异常综合症(MDS)。 ABVC开发了一个适应症,ABV-1703,用于治疗胰腺癌。 公司已经开发了ABV-1601,用于治疗癌症患者的抑郁症。 ABV-1701是玻璃体切除术的玻璃体替代物。
Industry: | Bio Therapeutic Drugs |
44370 Old Warm Springs Blvd
FREMONT
CALIFORNIA 94538-6148
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球530,000万多名交易者的一份子,选择利用Capital.com进行交易吧。